Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

13th Process Development for Highly Potent Drugs Summit (HPAPI)

Evvnt Promotion / evvnt
-
25.06.2024 - 27.06.2024  Delta Hotel Philadelphia Airport, 500 Stevens Drive, 19113 Philadelphia, Pennsylvania, USA
Time: 1:30 PM - 3:45 PM
 
Temi della conferenza
From Process Safety to Rapid Scale-Up to Tech Transfer: Integrating Process Development, Industrial Hygiene and Equipment Selection to Achieve GMP Manufacturing of Novel High Potent Drug Compounds 2023 has been a pivotal year for novel high potent compounds securing early success and approvals – from Henlius’s ADC to Gilead’s Trodelvy to BMS’s Augtyro, cementing the growth of highly potent drugs market to reach USD$40.7bn by 2023.
Professional congress organizer (PCO)
Hanson Wade Group
Annotazioni
URL:
Brochure: https://go.evvnt.com/2316046-3?pid=4832

Speakers: Antonio Hernandez-Cardoso, Senior Principal Scientist, US Pharmacopiea, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2316046-2?pid=4832
Ms. Gracia Carr
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5197.00
I partecipanti attesi
1000 - 1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

European Public Health Association (EUPHA)Ärzte der WeltAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationSwiss Tropical and Public Health InstituteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioCenter of Excellence